The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients

被引：0

作者：

Vanassche, Thomas ^{[1
]}

Engelen, Matthias M. ^{[1
,11
]}

Orlando, Christelle ^{[2
]}

Vandenbosch, Kristel ^{[3
]}

Gadisseur, Alain ^{[4
]}

Hermans, Cedric ^{[5
]}

Jochmans, Kristin ^{[2
]}

Minon, Jean-Marc ^{[6
]}

Motte, Serge ^{[7
]}

Peperstraete, Harlinde ^{[8
]}

Peters, Pierre ^{[3
]}

Sprynger, Muriel ^{[9
]}

Lancellotti, Patrizio ^{[9
]}

Dehaene, Isabelle ^{[10
]}

Emonts, Patrick

Vandenbriele, Christophe ^{[1
]}

Verhamme, Peter ^{[1
]}

Oury, Cecile

机构：

[1] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium

[2] Univ Ziekenhuis Brussel, Vrije Univ Brussel VUB, Dept Haematol, Brussels, Belgium

[3] CHU Univ Hosp Liege, Dept Lab Haematol, Liege, Belgium

[4] Antwerp Univ Hosp, Dept Haematol, Antwerp, Belgium

[5] Dept Haematol, Brussels, Belgium

[6] CHR Citadelle, Dept Lab Med, Thrombosis Haemostasis & Transfus Unit, Liege, Belgium

[7] Erasme Univ Hosp, Dept Vasc Dis, Brussels, Belgium

[8] Ghent Univ Hosp, Dept Cardiac Intens Care, Ghent, Belgium

[9] CHU Univ Hosp Liege, Dept Cardiol, Liege, Belgium

[10] Univ Ziekenhuis Gent, Vlaamse Vereniging Obstet Gynaecol, Ghent, Belgium

[11] Univ Leuven, Dept Cardiovasc Sci, Herestr 49 O&N1 Box 911, B-3000 Leuven, Belgium

来源：

ACTA CLINICA BELGICA | 2023年 / 78卷 / 06期

关键词：

Practice guideline; COVID-19; thrombosis; anticoagulants; MOLECULAR-WEIGHT HEPARIN; CORONAVIRUS DISEASE 2019; ILL ICU PATIENTS; OPEN-LABEL; MULTICENTER; THROMBOPROPHYLAXIS; RIVAROXABAN; OUTPATIENTS; GUIDELINES; MORTALITY;

D O I：

10.1080/17843286.2023.2241692

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

COVID-19 is associated with an increased risk for thrombotic complications. The trials investigating the optimal thromboprophylactic dose are performed in challenging times and seemingly produce conflicting evidence. The burdensome circumstances, divergent endpoints, and different analytical approaches hamper comparison and extrapolation of available evidence. Most importantly, clinicians should provide thromboprophylaxis in hospitalized COVID-19 patients while (re)assessing bleeding and thrombotic risk frequently. The COVID-19 Thromboprophylaxis Working Group of the BSTH updated its guidance document. It aims to summarize the available evidence critically and to guide clinicians in providing the best possible thromboprophylaxis.

引用

页码：497 / 508

页数：12

共 50 条

[1] Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19
Vanassche, Thomas
Orlando, Christelle
Vandenbosch, Kristel
Gadisseur, Alain
Hermans, Cedric
Jochmans, Kristin
Minon, Jean-Marc
Motte, Serge
Peperstraete, Harlinde
Peters, Pierre
Sprynger, Muriel
Lancellotti, Patrizio
Dehaene, Isabelle
Emonts, Patrick
Vandenbriele, Christophe
Verhamme, Peter
Oury, Cecile
ACTA CLINICA BELGICA, 2022, 77 (02) : 280 - 285
[2] Anticoagulation in hospitalized patients with COVID-19
Kreuziger, Lisa Baumann
Sholzberg, Michelle
Cushman, Mary
BLOOD, 2022, 140 (08) : 809 - 814
[3] Anticoagulation in COVID-19 patients - An updated systematic review and meta-analysis
Reis, Stefanie
Faske, Amon
Monsef, Ina
Langer, Florian
Mueller, Oliver J.
Kranke, Peter
Meybohm, Patrick
Weibel, Stephanie
THROMBOSIS RESEARCH, 2024, 238 : 141 - 150
[4] Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients
Russo, Vincenzo
Bottino, Roberta
D'Andrea, Antonello
Silverio, Angelo
Di Maio, Marco
Golino, Paolo
Nigro, Gerardo
Valsecchi, Orazio
Attena, Emilio
Canonico, Mario Enrico
Galasso, Gennaro
Parodi, Guido
Scudiero, Fernando
CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (04) : 705 - 712
[5] COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination
Stevens, Hannah
Ruiz-Carmona, Sergio
Peter, Karlheinz
McFadyen, James D.
HAEMATOLOGICA, 2023, 108 (09) : 2503 - 2506
[6] 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Schulman, Sam
Arnold, Donald M.
Bradbury, Charlotte A.
Broxmeyer, Lisa
Connors, Jean Marie
Falanga, Anna
Iba, Toshiaki
Kaatz, Scott
Levy, Jerrold H.
Middeldorp, Saskia
Minichiello, Tracy
Nazy, Ishac
Ramacciotti, Eduardo
Resnick, Helaine E.
Samama, Charles Marc
Sholzberg, Michelle
Thachil, Jecko
Zarychanski, Ryan
Spyropoulos, Alex C.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (06) : 1779 - 1797
[7] Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients
Vincenzo Russo
Roberta Bottino
Antonello D’Andrea
Angelo Silverio
Marco Di Maio
Paolo Golino
Gerardo Nigro
Orazio Valsecchi
Emilio Attena
Mario Enrico Canonico
Gennaro Galasso
Guido Parodi
Fernando Scudiero
Cardiovascular Drugs and Therapy, 2022, 36 : 705 - 712
[8] Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Nadkarni, Girish N.
Lala, Anuradha
Bagiella, Emilia
Chang, Helena L.
Moreno, Pedro R.
Pujadas, Elisabet
Arvind, Varun
Bose, Sonali
Charney, Alexander W.
Chen, Martin D.
Cordon-Cardo, Carlos
Dunn, Andrew S.
Farkouh, Michael E.
Glicksberg, Benjamin S.
Kia, Arash
Kohli-Seth, Roopa
Levin, Matthew A.
Timsina, Prem
Zhao, Shan
Fayad, Zahi A.
Fuster, Valentin
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (16) : 1815 - 1826
[9] Anticoagulation for COVID-19 Patients: A Bird's-Eye View
Kreidieh, Firas
Temraz, Sally
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
[10] Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Zhang, Sirui
Li, Yupei
Liu, Guina
Su, Baihai
THROMBOSIS JOURNAL, 2021, 19 (01)

← 1 2 3 4 5 →